🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Pfizer takes more steps to manage medicine stock at North Carolina plant

Published 08/03/2023, 02:45 PM
Updated 08/03/2023, 04:00 PM
© Reuters. FILE PHOTO: The roof of a Pfizer facility shows heavy damage after a tornado passed the area in Rocky Mount, North Carolina, U.S. July 19, 2023.  ABC Affiliate WTVD via REUTERS/File Photo
PFE
-

(Reuters) -Pfizer Inc said on Thursday it will begin making some products available only through its emergency ordering process, as part of steps to manage inventory at its North Carolina facility that was struck by a tornado last month.

The drugmaker said it was taking additional steps out of an abundance of caution as it released a list of 12 unique or specific presentations of nine products with high medical need.

The company's Rocky Mount plant is one of the world's largest factories for sterile injectable medicines. Its products include anesthetics, painkillers and anti-infective medicines for use in hospitals.

Nearly 25% of Pfizer (NYSE:PFE)'s sterile injectables used in U.S. hospitals are produced there, according to the company's website.

Pfizer's list includes injections for dextrose, sodium chloride and the heart failure medication dobutamine - these can only be ordered via direct shipment from the company or its representatives until further notice.

The tornado that struck the site completely destroyed the warehouse, but production facilities there did not suffer major damage, Pfizer had said earlier.

Earlier this week, CEO Albert Bourla said the company is still assessing how long it will take to bring the plant back on line.

© Reuters. FILE PHOTO: The roof of a Pfizer facility shows heavy damage after a tornado passed the area in Rocky Mount, North Carolina, U.S. July 19, 2023.  ABC Affiliate WTVD via REUTERS/File Photo

Pfizer also said hospitals should check the availability of these products with their wholesalers or distributors and look for appropriate therapeutic alternatives before placing emergency orders.

The company said that for all other products manufactured at the plant that were not included in the list and currently available in the distribution chain, customers will continue to receive their orders.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.